If you could vote on Brexit now which option would you choose?

J&J Covid-19 vaccine performs well in early tests

A single dose of Johnson & Johnson’s experimental coronavirus vaccine elicited “robust” protection against Covid-19 when tested on animals, with clinical human trials now under way in the US and Belgium. The pre-clinical data, published in Nature magazine, show the drugmaker’s dose successfully prevented subsequent infection in non-human primates, spurring so-called “neutralising antibodies”. It also provided complete or near-complete protection against Covid-19 in their lungs. “The findings give us confidence as we progress our vaccine development and upscale manufacturing in parallel,” said Paul Stoffels, J&J’s chief scientific officer.

The Financial Times - July 30, 2020

View the full story here: https://www.ft.com/content/a983341f-4066-4ace-8b0a-43f4c82d63a9